Investigation of The Prevalence of Sepsis in Adults in Multicenter Intensive Care Unıts in Turkey
NCT ID: NCT03179189
Last Updated: 2017-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2017-10-01
2018-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiology of Sepsis in Turkish ICUs.
NCT03249246
Validation of SOFA-2 for Mortality and Sepsis-3 Prevalence in Turkey
NCT07300306
Evaluation of Candidate Biomarkers to Predict Disease Severity and Acute Kidney Injury in Sepsis Patients
NCT05310812
İntensive Care Sepsis Prevelance in Turkey (INSEP-TURK)
NCT07283588
Effectiveness of the Cytokine Hemadsorption on Sepsis
NCT05057455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We aimed to evaluate the approach to sepsis in Turkey as a multi-centered study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Izmir Ataturk Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ilhan bahar
MD,Critical care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ataturk education research izmir
Izmir, Karabaglar, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/77
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.